RT Journal Article SR Electronic T1 Practical considerations for measuring the effective reproductive number, Rt JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.06.18.20134858 DO 10.1101/2020.06.18.20134858 A1 Gostic, Katelyn M. A1 McGough, Lauren A1 Baskerville, Edward B. A1 Abbott, Sam A1 Joshi, Keya A1 Tedijanto, Christine A1 Kahn, Rebecca A1 Niehus, Rene A1 Hay, James A1 De Salazar, Pablo M. A1 Hellewell, Joel A1 Meakin, Sophie A1 Munday, James A1 Bosse, Nikos I. A1 Sherrat, Katharine A1 Thompson, Robin N. A1 White, Laura F. A1 Huisman, Jana S. A1 Scire, Jérémie A1 Bonhoeffer, Sebastian A1 Stadler, Tanja A1 Wallinga, Jacco A1 Funk, Sebastian A1 Lipsitch, Marc A1 Cobey, Sarah YR 2020 UL http://medrxiv.org/content/early/2020/08/28/2020.06.18.20134858.abstract AB Estimation of the effective reproductive number, Rt, is important for detecting changes in disease transmission over time. During the COVID-19 pandemic, policymakers and public health officials are using Rt to assess the effectiveness of interventions and to inform policy. However, estimation of Rt from available data presents several challenges, with critical implications for the interpretation of the course of the pandemic. The purpose of this document is to summarize these challenges, illustrate them with examples from synthetic data, and, where possible, make recommendations. For near real-time estimation of Rt, we recommend the approach of Cori et al. (2013), which uses data from before time t and empirical estimates of the distribution of time between infections. Methods that require data from after time t, such as Wallinga and Teunis (2004), are conceptually and methodologically less suited for near real-time estimation, but may be appropriate for retrospective analyses of how individuals infected at different time points contributed to spread. We advise against using methods derived from Bettencourt and Ribeiro (2008), as the resulting Rt estimates may be biased if the underlying structural assumptions are not met. Two key challenges common to all approaches are accurate specification of the generation interval and reconstruction of the time series of new infections from observations occurring long after the moment of transmission. Naive approaches for dealing with observation delays, such as subtracting delays sampled from a distribution, can introduce bias. We provide suggestions for how to mitigate this and other technical challenges and highlight open problems in Rt estimation.Author summary The effective reproductive number, Rt, is a key epidemic parameter used to assess whether an epidemic is growing, shrinking or holding steady. Rt estimates can be used as a near real-time indicator of epidemic growth or to assess the effectiveness of interventions. But due to delays between infection and case observation, estimating Rt in near real-time, and correctly inferring the timing of changes in Rt is challenging. Here, we provide an overview of challenges and best practices for accurate, timely Rt estimation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementKG was supported by the James S. McDonnell Foundation. LM was supported by the National Institute Of General Medical Sciences of the National Institutes of Health under Award Number F32GM134721. ML acknowledges support from the Morris-Singer Fund and from Models of Infectious Disease Agent Study (MIDAS) cooperative agreement U54GM088558 from the National Institute Of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of General Medical Sciences or the National Institutes of Health. LFW acknowledges support from the National Institutes of Health (R01 GM122876). SA, JH, SM, JM, NIB, KS, RNT, SF acknowledge funding from the Wellcome Trust (210758/Z/18/Z). Thanks to Christ Church (Oxford) for funding via a Junior Research Fellowship (RNT). This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under CEIRS Contract No. HHSN272201400005C (SC).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study does not analyze any data from human or animal subjects.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis is a theoretical study analyzing only synthetic data. All code to generate and analyze the data is publicly available on Github (url provided within the text). https://github.com/cobeylab/Rt_estimation